Inventor · disambiguated record
Dan Chalothorn
Also filed as: CHALOTHORN DAN
6 granted patents·3 pending applications·2 citations·filing 2017–2023
69Inventor score
Files withREGENERON PHARMA9
Top patents by PatentIndex Score
9 records- 0180US11737435B2Non-human animals comprising a humanized coagulation factor 12 locusREGENERON PHARMA·Filed 2020·Granted Aug 29, 2023·1 cites·17 claims
- 0280US11622547B2Genetically modified mouse that expresses human albuminREGENERON PHARMA·Filed 2020·Granted Apr 11, 2023·1 cites·12 claims
- 0377US12201096B2Non-human animals comprising a humanized coagulation factor 12 locusREGENERON PHARMA·Filed 2023·Granted Jan 21, 2025·0 cites·16 claims
- 0474US12317874B2Method of using a genetically modified mouse that expresses human albuminREGENERON PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·30 claims
- 0566US2024190996A1Factor xi catalytic domain-binding antibodies and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0659US12304969B2Factor XI A2 domain-binding antibodies and methods of use thereofREGENERON PHARMA·Filed 2022·Granted May 20, 2025·0 cites·20 claims
- 0743US2018008672A1Anti-activin a antibodies and methods of use thereof for treating pulmonary arterial hypertensionREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 0840US12068729B2Anti-factor XII/XIIa antibodies and uses thereofREGENERON PHARMA·Filed 2019·Granted Aug 20, 2024·0 cites·31 claims
- 0938US2018057580A1Anti-gremlin-1 (grem1) antibodies and methods of use thereof for treating pulmonary arterial hypertensionREGENERON PHARMA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dan Chalothorn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →